Tarsus Pharmaceuticals, Inc. (TARS)
61.35
-0.20
(-0.32%)
USD |
NASDAQ |
Jun 10, 16:00
61.35
0.00 (0.00%)
After-Hours: 17:40
Tarsus Pharmaceuticals Max Drawdown (5Y) : 77.67% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 77.67% |
| April 30, 2026 | 77.67% |
| March 31, 2026 | 77.67% |
| February 28, 2026 | 77.67% |
| January 31, 2026 | 77.67% |
| December 31, 2025 | 77.67% |
| November 30, 2025 | 77.67% |
| October 31, 2025 | 77.67% |
| September 30, 2025 | 77.67% |
| August 31, 2025 | 77.67% |
| July 31, 2025 | 77.67% |
| June 30, 2025 | 77.67% |
| May 31, 2025 | 77.67% |
| April 30, 2025 | 77.67% |
| March 31, 2025 | 77.67% |
| February 28, 2025 | 77.67% |
| January 31, 2025 | 77.67% |
| December 31, 2024 | 77.67% |
| November 30, 2024 | 77.67% |
| October 31, 2024 | 77.67% |
| September 30, 2024 | 77.67% |
| August 31, 2024 | 77.67% |
| July 31, 2024 | 77.67% |
| June 30, 2024 | 77.67% |
| May 31, 2024 | 77.67% |
| Date | Value |
|---|---|
| April 30, 2024 | 77.67% |
| March 31, 2024 | 77.67% |
| February 29, 2024 | 77.67% |
| January 31, 2024 | 77.67% |
| December 31, 2023 | 77.67% |
| November 30, 2023 | 77.67% |
| October 31, 2023 | 77.67% |
| September 30, 2023 | 77.67% |
| August 31, 2023 | 77.67% |
| July 31, 2023 | 77.67% |
| June 30, 2023 | 77.67% |
| May 31, 2023 | 77.67% |
| April 30, 2023 | 77.67% |
| March 31, 2023 | 77.67% |
| February 28, 2023 | 77.67% |
| January 31, 2023 | 77.67% |
| December 31, 2022 | 77.67% |
| November 30, 2022 | 77.67% |
| October 31, 2022 | 77.67% |
| September 30, 2022 | 77.67% |
| August 31, 2022 | 77.67% |
| July 31, 2022 | 77.67% |
| June 30, 2022 | 77.67% |
| May 31, 2022 | 77.67% |
| April 30, 2022 | 70.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Structure Therapeutics, Inc. | -- |
| Eton Pharmaceuticals, Inc. | 79.94% |
| Alumis, Inc. | -- |
| Veradermics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 3.529 |
| Beta (5Y) | 0.4897 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.94% |
| Historical Sharpe Ratio (5Y) | 0.1533 |
| Historical Sortino (5Y) | 0.319 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.57% |